Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy.

Gao, Y; Jin, H

Gao, Y; Jin, H.

Affiliation

Gao Y; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.
Jin H; Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.

J Eur Acad Dermatol Venereol ; 36(1): e46-e48, 2022 Jan.

Article in En | MEDLINE | ID: mdl-34416092

Subject(s)

Livedo Reticularis; Livedoid Vasculopathy; Skin Diseases, Vascular; Humans; Livedo Reticularis/drug therapy; Pain Management; Skin Diseases, Vascular/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Diseases, Vascular / Livedo Reticularis / Livedoid Vasculopathy Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google